Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 733,235 | 862,853 | 812,987 | 705,709 | 604,718 |
| Cost of Goods | 42,614 | 43,874 | 39,869 | 38,028 | 29,220 |
| Gross Profit | 690,621 | 818,979 | 773,118 | 667,681 | 575,498 |
| Operating Expenses | 574,695 | 709,119 | 538,577 | 526,873 | 476,921 |
| Operating Income | 116,540 | 110,734 | 235,410 | 140,836 | 98,797 |
| Interest Expense | 680 | 752 | 439 | 358 | 359 |
| Other Income | -45,325 | 10,038 | -25,502 | 31,155 | -29,116 |
| Pre-tax Income | 70,535 | 120,020 | 209,469 | 171,633 | 69,322 |
| Income Tax | 32,543 | -443,831 | 27,730 | 22,177 | 15,787 |
| Net Income Continuous | 37,992 | 563,851 | 181,739 | 149,456 | 53,535 |
| Net Income | $37,992 | $563,851 | $181,739 | $149,456 | $53,535 |
| EPS Basic Total Ops | 0.17 | 2.56 | 0.82 | 0.68 | 0.24 |
| EPS Basic Continuous Ops | 0.17 | 2.56 | 0.82 | 0.68 | 0.24 |
| EPS Diluted Total Ops | 0.17 | 2.54 | 0.82 | 0.67 | 0.24 |
| EPS Diluted Continuous Ops | 0.17 | 2.54 | 0.82 | 0.67 | 0.24 |
| EBITDA(a) | $132,978 | $125,592 | $250,101 | $155,293 | $112,635 |